Macro International reports standalone net loss of Rs 0.01 crore in the September 2021 quarter

Price return has been average, nothing exciting

Performance

Seems to be overvalued vs the market average

Valuation

Strong financials and growth story over the years

Growth

Average profitability - not good, not bad

Profitability

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Astal Laboratories Ltd is engaged in the pharmaceutical bulk drug business, owning a manufacturing plant for pharmaceutical intermediates in Karnataka.

Astal Laboratories Ltd

Astal Laboratories Ltd

Scorecard

News & Opinions

Macro International reports standalone net loss of Rs 0.01 crore in the September 2021 quarter